id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0827-0003,FDA,FDA-2011-N-0827,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Revisions to Labeling Requirements for Blood and Blood Components, Including Source Plasma",Notice,General Notice,2012-04-25T04:00:00Z,2012,4,2012-04-25T04:00:00Z,,2012-04-25T14:27:37Z,2012-09894,0,0,0900006480ffafbc
FDA-2011-N-0827-0002,FDA,FDA-2011-N-0827,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Revisions to Labeling Requirements for Blood and Blood Components, Including Source Plasma; Correction",Notice,Notice of Extension,2012-02-08T05:00:00Z,2012,2,2012-02-08T05:00:00Z,2012-04-10T03:59:59Z,2012-02-08T14:16:09Z,2012-02827,0,0,0900006480fb033b
FDA-2011-N-0827-0001,FDA,FDA-2011-N-0827,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Labeling Requirements for Blood and Blood Components, Including Source Plasma; Revisions",Notice,General Notice,2011-12-30T05:00:00Z,2011,12,2011-12-30T05:00:00Z,2012-02-29T04:59:59Z,2011-12-30T14:28:59Z,2011-33555,0,0,0900006480f8b750